PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28433569-5	2017	METHODS: Patients treated with DAPT (ASA and clopidogrel or ticagrelor) for an ACS or elective PCI were scheduled for platelet function assessment at 30-90days post-discharge.	Ticagrelor	60-70	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	Homo sapiens	79-82	
25896573-26	2015	Well-audited data are needed from a long-term UK clinical registry on defined ACS patient groups treated with PCI who receive prasugrel, ticagrelor and clopidogrel.	Ticagrelor	137-147	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	Homo sapiens	78-81	
29954720-0	2019	Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.	Ticagrelor	105-115	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	Homo sapiens	88-91	
23474908-2	2013	A two-part decision model was adapted to compare treatment with ticagrelor or clopidogrel in a low-dose acetylsalicylic acid (ASA) cohort (<=150 mg) for all ACS patients and subtypes NSTEMI/IA and STEMI.	Ticagrelor	64-74	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	Homo sapiens	160-163	
23474908-12	2013	Hence, 12 months of ACS treatment using ticagrelor/ASA instead of clopidogrel/ASA may offer a cost-effective therapeutic option, even when the generic price for clopidogrel is employed.	Ticagrelor	40-50	1-aminocyclopropane-1-carboxylate synthase homolog (inactive)	Homo sapiens	20-23